Sjogren’s is not a simple disease. Nearly 40% of patients develop organ involvement, and the risk of lymphoma is 15 to 20 times that of the general population. It’s also a disease that’s often oversimplified as "just dryness"—even by rheumatologists.
Over the course of five groundbreaking episodes, you’ll hear from the world’s leading Sjogren’s experts, who will decode what every clinician needs to know: what Sjogren’s really looks like, what’s routinely being missed, and why over the next couple of years, everything is going to change.
This content is intended for medical professionals only.
All content for Decoding Sjogren’s Disease: A Clinical Deep Dive is the property of Health Monitor Network and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Sjogren’s is not a simple disease. Nearly 40% of patients develop organ involvement, and the risk of lymphoma is 15 to 20 times that of the general population. It’s also a disease that’s often oversimplified as "just dryness"—even by rheumatologists.
Over the course of five groundbreaking episodes, you’ll hear from the world’s leading Sjogren’s experts, who will decode what every clinician needs to know: what Sjogren’s really looks like, what’s routinely being missed, and why over the next couple of years, everything is going to change.
This content is intended for medical professionals only.
‘I Can’t Think, I Can’t Work’: The Hidden Toll of Sjogren’s
Decoding Sjogren’s Disease: A Clinical Deep Dive
10 minutes
1 month ago
‘I Can’t Think, I Can’t Work’: The Hidden Toll of Sjogren’s
We center the conversation on the lived experience of Sjogren’s—where fatigue, pain, and brain fog can eclipse even the most alarming lab results. We reveal the tools, strategies, and patient support systems that can transform quality of life and break the cycle of isolation so many patients endure.
About Dr. Teja Kapoor
Dr. Kapoor is the Director of the Columbia Sjogren’s Center and a leading advocate for earlier recognition and systemic management of Sjögren’s disease.
In this episode, we explore:
(00:00) Sjogren’s as an invisible illness
(02:54) Comparing Sjogren's to other autoimmune diseases – “even worse than death”
(03:34) Measuring the quality of a Sjogren's patient experience
(04:59) Evaluating Sjogren's syndrome tools
(07:29) Holistic approach in patient care
(08:11) If you take one thing from this episode...
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Decoding Sjogren’s Disease: A Clinical Deep Dive
Sjogren’s is not a simple disease. Nearly 40% of patients develop organ involvement, and the risk of lymphoma is 15 to 20 times that of the general population. It’s also a disease that’s often oversimplified as "just dryness"—even by rheumatologists.
Over the course of five groundbreaking episodes, you’ll hear from the world’s leading Sjogren’s experts, who will decode what every clinician needs to know: what Sjogren’s really looks like, what’s routinely being missed, and why over the next couple of years, everything is going to change.
This content is intended for medical professionals only.
